Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic heterogeneity of cardiomyopathy and its correlation with patient care. | BMC Med Genomics | 2023 | 37904158 | PubTator, text mining | PubMed |
| The Role of Genetics in the Management of Heart Failure Patients. | Int J Mol Sci | 2023 | 37894902 | PubTator, text mining | PubMed |
| Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights. | Int J Mol Sci | 2023 | 37894777 | PubTator, text mining | PubMed |
| Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy. | J Clin Med | 2023 | 37892766 | PubTator, text mining | PubMed |
| MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy. | Circulation | 2023 | 37886847 | PubTator, text mining | PubMed |
| RNA modification in cardiovascular disease: implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37884527 | PubTator, text mining | PubMed |
| Multicenter Cohort Analysis Unveil Inherited Arrhythmia in Korea. | Korean Circ J | 2023 | 37880831 | PubTator, text mining | PubMed |
| CRISPR/Cas9 technology: applications in oocytes and early embryos. | J Transl Med | 2023 | 37875936 | PubTator, text mining | PubMed |
| Differentiating Cardiac Troponin Levels During Cardiac Myosin Inhibition or Cardiac Myosin Activation Treatments: Drug Effect or the Canary in the Coal Mine? | Curr Heart Fail Rep | 2023 | 37875744 | PubTator, text mining | PubMed |
| Beyond gene-disease validity: capturing structured data on inheritance, allelic requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions. | Genome Med | 2023 | 37872640 | PubTator, text mining | PubMed |
| Myosin and tropomyosin-troponin complementarily regulate thermal activation of muscles. | J Gen Physiol | 2023 | 37870863 | PubTator, text mining | PubMed |
| Drug discovery for heart failure targeting myosin-binding protein C. | J Biol Chem | 2023 | 37865311 | PubTator, text mining | PubMed |
| [Hypertrophic cardiomyopathy complicating with ventricular tachycardia induced by MYBPC3 and RYR2 double gene mutations: a case report]. | Zhonghua Xin Xue Guan Bing Za Zhi | 2023 | 37859363 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Reveals Mutational Signature of Hypertrophic Cardiomyopathy. | Int J Gen Med | 2023 | 37850193 | PubTator, text mining | PubMed |
| How Does It Work? Unraveling the Mysteries by Which Empagliflozin Helps Diabetic and Non-diabetic Patients With Heart Failure. | Cureus | 2023 | 37846252 | PubTator, text mining | PubMed |
| Characterization of heterozygous and homozygous mouse models with the most common hypertrophic cardiomyopathy mutation MYBPC3c.2373InsG in the Netherlands. | J Mol Cell Cardiol | 2023 | 37844837 | PubTator, text mining | PubMed |
| Multimodality Imaging in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation. | Diagnostics (Basel) | 2023 | 37835790 | PubTator, text mining | PubMed |
| Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts. | Int J Mol Sci | 2023 | 37834293 | PubTator, text mining | PubMed |
| Fractalkine/CX3CR1 in Dilated Cardiomyopathy: A Potential Future Target for Immunomodulatory Therapy? | Cells | 2023 | 37830591 | PubTator, text mining | PubMed |
| The burden of splice-disrupting variants in inherited heart disease and unexplained sudden cardiac death. | NPJ Genom Med | 2023 | 37821546 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=19